Gapping up
In reaction to disappointing earnings/guidance:
- STNE +22%, SYNH +10.9%, AMRS +5.5% (also signed agreement for cannabinoid development, licensing and commercialization containing $300 million of R&D and milestone payments plus long-term royalties), MIK +4.7%, TLRY +3.2%, HDS +1%
Other news:
- FOE +7% (to join S&P SmallCap 600)
- PAGS +5.8% (attributed to STNE results)
- AMRS +5.5% (Amyris signed final definitive agreement for cannabinoid development, licensing and commercialization containing $300 million of R&D and milestone payments plus long-term royalties)
- BIOS +4.3% (modestly rebounding from 16% decline)
- DERM +2.7% (proposed public offering of $110.0 mln of its common stock)
- CTRE +1.8% (increases quarterly dividend to $0.225/share from $0.205/share)
- WMB +1.3% (Williams Cos and Canada Pension Plan form $3.8 bln strategic joint venture partnership in the Marcellus/Utica basins )
- F +0.5% (increasing production of Ford Expedition and Lincoln Navigator this summer by 20% to meet surging customer demand, adding 550 jobs at Kentucky Truck Plant in Louisville)
Analyst comments:
- ZUO +3.6% (upgraded to Buy from Hold at Canaccord Genuity)
- AAXN +2.7% (upgraded to Buy from Neutral at Northcoast)
- DPZ +2% (upgraded to Overweight from Neutral at JP Morgan)
- SCCO +1.9% (upgraded to Hold from Reduce at HSBC Securities)
- FLWS +1.6% (upgraded to Buy from Neutral at DA Davidson)
- FIVE +1.4% (upgraded to Buy from Hold at Loop Capital)
- NBL +1.3% (upgraded to Buy from Neutral at Mizuho)
